Genotype-phenotype correlation in aHUS
. | Frequency (%) . | ESRD/death (%) . | Relapse (%) . | Recurrence in transplanted kidney . |
---|---|---|---|---|
CFH | 23-27 | 63-80 | 20-40 | 80-90 |
CFI | 3-8 | 50-70 | 20-40 | 70-80 |
C3 | 2-8 | 43-60 | 20-40 | 40-50 |
MCP | 5-9 | 17-20 | 80 | 15-20 |
CFB | 1-2 | 70 | 70 | 88 |
Anti-FH Ab | 3-6 | 30 | 60* 10† | 20 |
THBD | 0-5 | 60 | — | — |
Combined | 4 | — | — | — |
No mutation | 33-54 | 27 | 20-40 | 27 |
. | Frequency (%) . | ESRD/death (%) . | Relapse (%) . | Recurrence in transplanted kidney . |
---|---|---|---|---|
CFH | 23-27 | 63-80 | 20-40 | 80-90 |
CFI | 3-8 | 50-70 | 20-40 | 70-80 |
C3 | 2-8 | 43-60 | 20-40 | 40-50 |
MCP | 5-9 | 17-20 | 80 | 15-20 |
CFB | 1-2 | 70 | 70 | 88 |
Anti-FH Ab | 3-6 | 30 | 60* 10† | 20 |
THBD | 0-5 | 60 | — | — |
Combined | 4 | — | — | — |
No mutation | 33-54 | 27 | 20-40 | 27 |
Based on the data provided in Noris et al,8 Noris and Remuzzi,11 Bu et al,13 and Loirat et al.14
Ab, antibody; CFB, factor B; CFH, factor H; CFI, factor I.
*Without immunosuppression.
†With immunosuppression.